Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ALung Technologies logo — Respiratory Dialysis Through Extracorporeal Low Flow CO₂ Rem...

ALung Technologies

Respiratory Dialysis Through Extracorporeal Low Flow CO₂ Removal (ECCO₂R)

Founded 1997 United States Pittsburgh, United States 11 employees Debt Financing Total: $112.90M Biotechnology, Health Care +2

General Information

Company Name ALung Technologies
Founded Year 1997
Location United States Pittsburgh, United States
Founders / Decision Makers
Team member Team member Team member
Employees 11
Industries Biotechnology, Health Care, Health and Wellness +1
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with ALung Technologies. To contact ALung Technologies, visit alung.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ALung Technologies compare?

A PDF of ALung Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ALung Technologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ALung Technologies

ALung Technologies is a medical device company that has been pioneering respiratory solutions through innovative gas exchange devices since its inception in 1997. Based in Pittsburgh, Pennsylvania, the company specializes in developing gas exchange devices for both acute and chronic respiratory disorders. Their notable innovations include the Hemolung, which circulates blood through a small catheter for gas exchange, and the Hattler Catheter, designed for placement within the central venous bloodstream and inserted directly through the skin. In its most recent funding round at 12 November 2020, ALung Technologies secured a $5.44M Debt Financing investment. This infusion of capital will likely support the company's efforts to further develop and commercialize its innovative respiratory solutions. Although the specific investors in this latest round have not been disclosed, it signifies a continued interest in the company's mission to advance respiratory care through technological innovation. ALung Technologies' focus on addressing critical respiratory needs positions it well for potential growth and impact within the Biotechnology and Healthcare sectors.

Business keywords: Gas Exchange Devices, Respiratory Disorders, Hemolung, Hattler Catheter, Acute Respiratory Disorders, Chronic Respiratory Disorders, Intracorporeal Gas Exchange Devices, Extracorporeal Gas Exchange Devices, Critical Care Medicine, Intensive Care Medicine, ECCO2R, Pittsburgh, Pennsylvania

Funding Rounds & Investors (11)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $5.44M -
12 Nov 2020
Debt Financing $2.00M -
01 Jun 2020
Venture Round $3.26M -
10 Feb 2020
Series D $5.00M -
08 Jan 2019
Series C $36.00M 8
Allos Ventures Birchmere Ventures Riverfront Ventures
Allos Ventures, Birchmere Ventures +6
11 Apr 2017
Series B $10.00M 2
Allos Ventures West Capital Advisors
Allos Ventures, West Capital Advisors
19 May 2014
Series B $15.80M 9
Allos Ventures Birchmere Ventures Pittsburgh Life Sciences Greenhouse
Allos Ventures, Birchmere Ventures +7
11 Sep 2013
Series B $10.00M 2
Birchmere Ventures
Birchmere Ventures, Eagle Ventures
06 Feb 2012
Venture Round $8.81M -
11 Nov 2011
Series A $14.00M 3
Birchmere Ventures
Birchmere Ventures, MAG Ventures +1
11 Oct 2010

View All 11 Funding Rounds

ALung Technologies Alternatives & Competitors

View All Alternatives
ALung Technologies vs
Biosys
Biosys Turkey

Innovative Care Powered by Technology | Respiratory, ICU, IONM & Advanced Medical Technologies

203 employees
Digital Health, Health Care
ALung Technologies vs
Gwinnett Pulmonary Group
Gwinnett Pulmonary Group United States

Lung Health Starts Here

42 employees
Health Care, Health and Wellness
ALung Technologies vs
Airway Innovations LLC
Airway Innovations LLC United States

Improving outcomes for Respiratory Patients

Seed
1 employees
Health Care, Medical Devices
View all alternatives

FAQ About ALung Technologies

Respiratory Dialysis Through Extracorporeal Low Flow CO₂ Removal (ECCO₂R)
ALung Technologies was founded in 1997.
ALung Technologies is headquartered in Pittsburgh, United States.
ALung Technologies operates in Biotechnology, Health Care, Health and Wellness and Medical Devices. Its work centres on Gas Exchange Devices, Respiratory Disorders, Hemolung and Hattler Catheter.
ALung Technologies has approximately 11 employees.
ALung Technologies has completed 11 funding rounds, raising a total of $112.90M. The latest funding stage is Debt Financing.
Top alternatives and competitors to ALung Technologies include Biosys, Gwinnett Pulmonary Group, Airway Innovations LLC, X-COR Therapeutics, Lungpacer Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ALung Technologies and Biosys are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ALung Technologies, https://bouncewatch.com/company/alung-technologies, updated 9 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes